|
|
U.S. Neurosurgical, Inc. - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for U.S. Neurosurgical, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
U.S. Neurosurgical, Inc.. The Group's principal activity is to own and operate stereotactic radiosurgery centers, utilizing the Gamma Knife technology. The Gamma Knife is a radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery. It owns and operates two Gamma Knife centers in Kansas City and New York. It's target market is medical centers in major health care catchment areas that have physicians experienced with and dedicated to use gamma knife. It operates throughout the United States.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|